SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Sharck Soup
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tom r. phillips who wrote (452)9/1/2000 11:39:10 AM
From: manny t  Read Replies (1) of 37746
 
BTRN now on Briefing:

11:30 ET Biotransplant Incorp. (BTRN) 13 11/16 +7/8 (+6.9%): On the move again after company presented data on a novel strategy for the induction of tolerance in pancreatic islet cell transplantation which may have practical application in pig-to-human xenotransplantation for the treatment of diabetes.... BTRN rallied earlier this week after presenting data indicating company may be able to develop a breed of pig that does not produce porcine endogenous retrovirus (PERV) capable of productively infecting human cells
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News